HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ferguson, T. Articles by Crimmins-Reda, P Search for Related Content PubMed PubMed Citation Articles by Ferguson, T., Jr Articles by Crimmins-Reda, P

J Thorac Cardiovasc Surg 1996;111:742-752
© 1996 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

THE ADDITIONAL HOSPITAL COSTS GENERATED IN THE MANAGEMENT OF COMPLICATIONS OF PACEMAKER AND DEFIBRILLATOR IMPLANTATIONS

From the Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, and Barnes Hospital at Washington University, St. Louis, Mo.

Received for publication April 27, 1996; Revisions requested August 17, 1995; revisions received Dec. 8, 1995 Accepted for publication Dec. 13, 1995. Address for reprints: Dr. T. Bruce Ferguson Jr. MD, Associate Professor of Surgery, Division of Cardiothoracic Surgery, Suite 3108 Queeny Tower, Barnes Hospital Plaza, St. Louis, MO 63110.

Abstract

The rapid approach of capitated reimbursement mandates that providers examine their practice patterns associated with all surgical procedures. Documentation of (1) the complications associated with these procedures and (2) the additional hospital costs associated with the management of these complications is critical for comprehensive fiscal accountability. This study analyzed (1) the feasibility of obtaining accurate hospital cost data specific for complications and (2) the outcome in terms of fully loaded hospital costs generated in the management of the most common surgical complications associated with pacemaker and nonthoracotomy implantable defibrillator therapies. Between July 1989 and September 1994, a total of 1031 pacemaker and 105 implantable defibrillator procedures were performed by a cardiac surgeon in a tertiary-level teaching hospital setting. The additional fully loaded hospital costs were determined by (1) correlating clinical data from the complete medical record with complete hospital charge data for the admission(s) related to the complication, (2) carving out complication-related charges based on the clinical data, (3) converting complication-related charges to fully loaded costs based on conversion factors in effect at the time of service, and (4) correlating cost with hospital net reimbursement and payor source. The feasibility study determined that accurate and reliable cost data specific to complications can be obtained, although the process was cumbersome and difficult. The outcomes study determined that mean fully loaded complication costs were $4345 ± $1540 for pacemaker lead revision and $4879 ± $3167 for implantable defibrillator lead dislodgment, $24,459 ± $14,585 for pacemaker infection, and $13,736 ± $12,505 for defibrillator generator system malfunction. The one infected defibrillator cost $57,213 to treat. Costs exceeded reimbursement for almost all Medicare patients with complications in this study, suggesting that similar shortfalls would occur under a capitation scheme. This information is critical to a complete understanding of the financial impact of interventional procedures in a capitated reimbursement environment. (J THORACCARDIOVASCSURG1996;111:742-52)

This article has been cited by other articles:

				R. Margey, H. McCann, G. Blake, E. Keelan, J. Galvin, M. Lynch, N. Mahon, D. Sugrue, and J. O'Neill Contemporary management of and outcomes from cardiac device related infections Europace, January 1, 2010; 12(1): 64 - 70. [Abstract] [Full Text] [PDF]

				J C Lekkerkerker, C van Nieuwkoop, S A Trines, J G van der Bom, A Bernards, E T van de Velde, M Bootsma, K Zeppenfeld, J W Jukema, J-W Borleffs, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry Heart, May 1, 2009; 95(9): 715 - 720. [Abstract] [Full Text] [PDF]

				J. C. de Oliveira, M. Martinelli, S. A. D. Nishioka, T. Varejao, D. Uipe, A. A. A. Pedrosa, R. Costa, and S. B. Danik Efficacy of Antibiotic Prophylaxis Before the Implantation of Pacemakers and Cardioverter-Defibrillators: Results of a Large, Prospective, Randomized, Double-Blinded, Placebo-Controlled Trial Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 29 - 34. [Abstract] [Full Text] [PDF]

				M. R. Sohail, D. Z. Uslan, A. H. Khan, P. A. Friedman, D. L. Hayes, W. R. Wilson, J. M. Steckelberg, S. M. Jenkins, and L. M. Baddour Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection Mayo Clin. Proc., January 1, 2008; 83(1): 46 - 53. [Abstract] [Full Text] [PDF]

				D. Klug, M. Balde, D. Pavin, F. Hidden-Lucet, J. Clementy, N. Sadoul, J. L. Rey, G. Lande, A. Lazarus, J. Victor, et al. Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study Circulation, September 18, 2007; 116(12): 1349 - 1355. [Abstract] [Full Text] [PDF]

				M. R. Sohail, D. Z. Uslan, A. H. Khan, P. A. Friedman, D. L. Hayes, W. R. Wilson, J. M. Steckelberg, S. Stoner, and L. M. Baddour Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections J. Am. Coll. Cardiol., May 8, 2007; 49(18): 1851 - 1859. [Abstract] [Full Text] [PDF]

				P. S. Chan, K. Stein, T. Chow, M. Fendrick, J. T. Bigger, and S. Vijan Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II-Eligible Population J. Am. Coll. Cardiol., July 4, 2006; 48(1): 112 - 121. [Abstract] [Full Text] [PDF]

				R. O. Darouiche Treatment of Infections Associated with Surgical Implants N. Engl. J. Med., April 1, 2004; 350(14): 1422 - 1429. [Full Text] [PDF]

				U.K.H Wiegand, J Potratz, F Bode, R Schreiber, H Bonnemeier, W Peters, and H.A Katus Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block? Eur. Heart J., January 2, 2001; 22(2): 174 - 180. [Abstract] [PDF]

				D. K. Owens, G. D. Sanders, R. A. Harris, K. M. McDonald, P. A. Heidenreich, A. D. Dembitzer, and M. A. Hlatky Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac Death Ann Intern Med, January 1, 1997; 126(1): 1 - 12. [Abstract] [Full Text]